Press Enter to search
.png)
Demand for off-site blood collection is climbing on every front. Hospital-at-home programs, Medicare Advantage in-home assessments, employer wellness draws, clinical trial home visits, skilled nursing facility (SNF) routes, and concierge laboratory services are all pushing more specimens out of fixed draw stations and into living rooms, conference rooms, and parked vans. The Centers for Medicare & Medicaid Services (CMS) Acute Hospital Care at Home waiver, extended again in recent reauthorizations, has made the model permanent enough for serious capital investment.
That growth comes with a quiet problem: the controls a hospital lab takes for granted—climate-controlled draw rooms, barcode-printed labels at the bedside, immediate centrifugation, runner pickups every hour—do not exist on a mobile route. A specimen that would be flawless in the outpatient lab can hemolyze in a hot trunk, mislabel in a cramped foyer, or expire in transit before it ever reaches the analyzer.
This guide walks through the equipment, infection-control practices, transport requirements, and workflow design that separate a safe, defensible mobile or home-health program from a chronic source of redraws and rejected specimens. It closes with a 90-day plan any phlebotomy or home-health program can adapt.
A defensible mobile kit is built from three layers: collection devices, infection-control supplies, and transport hardware. Every item below should be in every kit, every visit, with a documented restock SOP.
Collection Devices: Safety winged blood collection sets in 21G, 23G, and 25G; standard safety needles for routine adult draws; safety lancets for capillary samples; and a closed-system blood transfer device for any syringe-based draw. A consistent device portfolio across the route reduces the technique improvisation that drives errors. The RELI® Push Button Safety Blood Collection Set is well-suited for mobile work: one-handed activation matters when the collector is kneeling next to a recliner or balancing on the edge of a SNF bed.
Tube Inventory: A full color-coded set—light blue (citrate), red, gold/SST, green (lithium or sodium heparin), lavender (EDTA), gray (sodium fluoride/potassium oxalate)—plus pediatric microcollection tubes. Carry at least 25% over expected volume; you cannot run back to the lab for one extra blue top. Track lot numbers and expiration dates by visit; the home-health route is the most common source of expired-tube redraws.
Tube Holders and Adapters: A standardized RELI® Safety Blood Collection Tube Holder across the kit eliminates the "which holder fits which needle" hesitation that costs seconds at the bedside. Single-use holders also satisfy the Occupational Safety and Health Administration (OSHA) directive against reusing tube holders with attached needles.
Closed-System Transfer: A RELI® Blood Transfer Device — Female Luer or Male Luer configuration eliminates the open syringe-to-tube decanting that causes hemolysis and exposure incidents. For mobile draws originating from a difficult vein and a syringe, this device is non-negotiable.
Infusion Sets for Difficult Access: Safety-engineered RELI® Safety Slide Blood Collection / Infusion Sets provide gauge flexibility and stable hand position for fragile veins—common in geriatric home-health and oncology home visits.
Infection-Control Supplies: Alcohol prep pads, chlorhexidine swabs (for blood culture draws), single-use tourniquets (reusable tourniquets are a documented source of cross-contamination on home routes), gauze, self-adherent wrap, exam gloves in three sizes, surface disinfectant wipes registered with the U.S. Environmental Protection Agency (EPA) for bloodborne pathogens, and an OSHA-compliant biohazard spill kit.
Sharps and Waste Management: A leak-proof, puncture-resistant Food and Drug Administration (FDA)-cleared sharps container sized for the route (a quart container handles a typical day; a one-gallon for SNF routes). Secondary biohazard bags for contaminated gauze, gloves, and prep waste. A documented chain-of-custody for sharps disposal back at the home base—never in a residential trash bin.
Transport Hardware: A rigid, insulated specimen carrier with a temperature logger, refrigerant packs prepared the night before, a separate ambient-temperature compartment for tubes that must not be chilled (for example, cold agglutinin and cryoglobulin specimens are exceptions to the standard ambient/refrigerated rules), and a United Nations (UN) 3373 Category B compliant outer container with proper labeling for any specimen leaving the immediate site.
Identification and Documentation: A handheld barcode scanner with portable label printer (Bluetooth-paired to the route tablet), a backup paper requisition pad, two functioning ballpoint pens with archival ink, and a rugged tablet with offline-capable electronic health record (EHR) access for the day's visits.
Every home and off-site location should be treated as a potential biohazard zone the moment a sharp is exposed. The Centers for Disease Control and Prevention (CDC) Standard Precautions framework applies to every visit—not a relaxed version of it.
Hand Hygiene: Alcohol-based hand rub (60–95% ethanol or isopropanol) before patient contact, before clean procedure, after exposure to body fluids, after patient contact, and after contact with patient surroundings—the World Health Organization (WHO) Five Moments for Hand Hygiene. Soap and water if hands are visibly soiled. Carry your own; you cannot rely on the patient's sink.
Personal Protective Equipment (PPE): Gloves for every draw, no exceptions. A face mask whenever the patient is symptomatic, immunocompromised, or in a household with respiratory illness. A fluid-resistant gown for any visit with a documented airborne or contact precaution.
Surface Discipline: A single-use absorbent pad under the work area protects the patient's furniture and contains any spill. The kit itself never touches the floor, never sits on the bed, and never opens on a soft surface. A designated clean zone (laid-out supplies) and a designated dirty zone (used sharps, gauze, gloves) prevent cross-contamination between visits.
Between-Visit Reset: Disinfect the kit handles, scanner, tablet, and tourniquet (if reusable—single-use is preferred) with an EPA List K disinfectant at every stop. Replace gloves between every patient. Document the reset on the route log.
Specimen integrity is where most mobile programs fail their first inspection. The rules are well-defined and enforceable—and they apply whether the specimen travels in a courier van, a personal vehicle, or a backpack on a transit route.
Temperature Control: Most routine chemistry, hematology, and serology specimens are stable at ambient temperature (15–25 °C) for up to two hours and refrigerated (2–8 °C) for up to 24 hours, but every assay has its own stability window. Reference the Clinical and Laboratory Standards Institute (CLSI) GP44 guidance for handling and processing of blood specimens, and follow the receiving lab's specific requirements. Frozen specimens (for example, certain coagulation panels and ammonia) require dry ice and a separate compartment.
Order of Draw and Mixing: The CLSI order of draw applies on the road exactly as it does in the clinic: blood culture, then light blue (citrate), then red/gold/SST, then green, lavender, and gray. Invert each tube the manufacturer-specified number of times immediately after collection—not at the next stop, not at the lab. Inadequate mixing is the leading driver of clotted lavender-top specimens on home routes.
Time-to-Lab Tracking: Log the collection time, the time the tube enters the carrier, and the time it is delivered to the lab. The CLSI two-hour ambient stability rule is a hard ceiling for many analytes, including potassium, lactate dehydrogenase (LDH), and glucose. Routes designed for "all the labs at end of shift" are routes designed to fail proficiency testing.
Packaging for Public-Highway Transport: Diagnostic specimens travel under U.S. Department of Transportation (DOT) and International Air Transport Association (IATA) Category B (UN 3373) packaging rules: a leak-proof primary receptacle, an absorbent wrap, a leak-proof secondary container, and a rigid outer carrier with the UN 3373 diamond mark and the words "Biological Substance, Category B." See 49 CFR 173.199 for the U.S. ground-transport requirements. Plastic zip bags in a soft cooler do not satisfy this standard.
Documentation in Transit: A signed, time-stamped chain-of-custody travels with every batch. The receiving lab scans every tube on arrival and reconciles against the manifest before any specimen enters processing. Any discrepancy is logged and triaged before centrifugation.
The single biggest mistake in mobile programs is treating the home as a relaxed environment. The two-identifier verification, bedside labeling, and positive patient identification (PPID) requirements are exactly the same on a kitchen table as they are in an outpatient draw bay.
Confirm patient identity with two identifiers (full legal name and date of birth, or medical record number) verified against a photo ID or wristband when available, and stated aloud by the patient. In SNF and assisted-living settings, a wristband or chart confirmation is required—family identification alone is not enough.
Set up the clean zone before opening the kit. Position the patient with arm support and good lighting. Apply a single-use under-pad. Put on gloves only after the supplies are laid out, never before.
Perform the draw without interruption. If the home environment is loud, distracting, or unsafe (an aggressive pet, an unstable patient, an unsanitary surface), pause and reschedule. A documented decline-and-reschedule policy protects the program and the collector.
Label every tube in the patient's presence, before leaving the room, with date, time, and collector initials. Scan the wristband or printed identifier and the label barcode; never pre-label. The CLSI GP33 and Joint Commission NPSG.01.01.01 standards apply on the route exactly as they apply in the hospital.
Place labeled tubes directly into the transport carrier in the patient's home—not in a pocket, not on the cart, not in the front seat of the car. Document collection time on the manifest before stepping outside.
A home or workplace draw exposes the collector to risks that do not exist in a fixed clinic: unfamiliar pets, uneven flooring, distracted patients, second-floor walkups with awkward kit placement, and—occasionally—unsafe environments. A defensible program treats collector safety as a clinical control, not a soft policy.
Sharps Engineering: Every sharp in the kit must be a safety-engineered device with one-handed activation, per the OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030). Two-handed safety activation in a cluttered home is the most common pathway to a needlestick injury on the route. The auto-retracting design of the RELI® portfolio is specifically suited to single-handed activation with the dominant hand free for patient stabilization.
Visit Risk Screening: A pre-visit risk screen (animal in the home, mobility hazards, prior agitation history, household weapons, neighborhood safety) is documented for every new patient and reviewed before each visit. Two-collector visits are appropriate for any flagged risk.
Communication and Tracking: Real-time GPS visibility for every collector on a route, a documented panic-button and welfare-check protocol, and a daily visit-completion check-in. Solo collectors are never out of contact for more than a defined interval.
Vaccination and Post-Exposure: Hepatitis B vaccination documented for every collector, a documented post-exposure protocol with same-day occupational-health access, and a biohazard spill kit in every vehicle. Every exposure incident is reported and reviewed regardless of severity.
Mobile and home-health workflows reward standardization. A single, consistent device portfolio across every route reduces cognitive load, supports one-handed safety activation, and eliminates the technique improvisation that drives mislabeling and hemolysis on the road. The MYCO Medical RELI® portfolio is designed around exactly that consistency.
.png)
RELI® Push Button Safety Blood Collection Set (21G, 23G, 25G): One-handed safety activation keeps the dominant hand free for patient stabilization in cramped or unfamiliar home environments. Gauge flexibility supports geriatric, pediatric, and difficult-access draws on the same kit.
.png)
RELI® Safety Slide Blood Collection / Infusion Sets: Stable hand position and predictable safety activation for fragile-vein draws common in home-health and SNF settings.
.png)
RELI® Safety Blood Collection Tube Holder: A standardized single-use holder eliminates the OSHA-flagged practice of reusing holders with attached needles—a documented exposure pathway on mobile routes where holders are reused between visits to save kit weight.
.png)
.png)
RELI® Blood Transfer Device — Female Luer and Male Luer: Closed-system transfer eliminates the open syringe-to-tube decanting that causes hemolysis and exposure incidents on syringe-based draws—still common in home-health when vacuum-tube draws are not feasible.
Standardizing on one portfolio across every route, every kit, and every collector removes the most common driver of mobile errors: technique that adapts to the supply mix instead of the patient.
A defensible mobile or home-health blood collection program is not built in a memo. Here is a 90-day sequence any phlebotomy or home-health program can adapt to launch a new route or reset a struggling one.
Days 1–15: Baseline and Policy Alignment. Pull 90 days of historical mobile-route data: rejection rates, redraw rates, time-to-lab averages, exposure incidents, and patient complaints. Reconcile route policies against CLSI GP41 (collection), GP44 (handling and processing), GP33 (specimen labeling), the OSHA Bloodborne Pathogens Standard, and 49 CFR 173.199 (Category B transport). Publish a one-page route standard that closes every gap.
Days 16–30: Kit and Vehicle Standardization. Audit every kit, every vehicle, and every collector's personal supply hoard. Standardize on a single device portfolio, one tube manufacturer, and one transport carrier. Remove non-standard inventory. Deploy temperature loggers in every carrier. Verify every vehicle has a biohazard spill kit, a sharps container, and a current vehicle-safety check.
Days 31–60: Training and Competency. Run a mandatory 30-minute mobile competency session for every collector, including travelers and float staff. Cover the bedside identification and labeling sequence, the order of draw, tube inversion counts, time-to-lab tracking, Category B packaging, and the visit-risk-screen protocol. Require sign-off before independent route assignment. Run an unannounced ride-along with each collector in week eight.
Days 61–90: Measure, Coach, Sustain. Publish a monthly route-quality dashboard—rejection rate, redraw rate, time-to-lab, exposure incidents, and patient complaints—shared with route supervisors, the lab, and home-health operations. Trigger coaching on any collector above the program rejection target. Celebrate routes with sustained zero exposure incidents and zero specimen rejections.
You cannot manage a mobile program from anecdote. Track these key performance indicators (KPIs) monthly and share them with every stakeholder who touches the route:
Specimen rejection rate (%) | Target: < 1.0% | Monthly
Hemolysis rate on mobile draws (%) | Target: < 2.0% | Monthly
Mislabeling and wrong-patient events | Target: 0 | Monthly (and reported to patient safety)
Average collection-to-lab time (minutes) | Target: < 90 minutes | Daily, summarized monthly
Specimens exceeding ambient stability window (%) | Target: < 0.5% | Monthly
Needlestick or exposure incidents per 10,000 visits | Target: 0 | Monthly
Patient complaint rate per 1,000 visits | Target: < 1 | Monthly
Visit completion rate vs. scheduled (%) | Target: > 97% | Weekly
Per-collector blinded performance reporting—shared only with the supervisor and the collector—is the single most effective sustained-improvement lever for a mobile program. Clinicians respond quickly to data they can see about their own practice.
Pre-Visit: Patient identifiers confirmed against the day's manifest; kit restocked with current-dated tubes; temperature logger active in the carrier; sharps container has capacity; risk-screen flags reviewed; route tablet has offline EHR access.
On Arrival: Hand hygiene before patient contact; clean zone established with single-use under-pad; PPE applied; two-identifier verification stated aloud and confirmed.
During the Draw: Order of draw followed; tubes inverted the manufacturer-specified number of times immediately after collection; one-handed safety activation on every sharp.
Immediately After: Every tube labeled in the patient's presence, before leaving the room; barcode scan confirms wristband-to-label match; collection time recorded; tubes placed directly into the carrier.
Between Visits: Kit handles, scanner, and tablet wiped with EPA List K disinfectant; gloves replaced; single-use tourniquet discarded; route log updated with time-to-lab clock started.
End of Route: Specimens hand-delivered with signed chain-of-custody; manifest reconciled with receiving lab; vehicle-borne sharps and biohazard waste returned to home base; temperature log uploaded to the route record.
Standardized supplies support standardized workflow—and standardized workflow is what protects specimen integrity, collector safety, and patient experience on the road. Explore the full RELI® Blood Collection portfolio to see how MYCO Medical supports mobile and home-health programs from kit design to the receiving lab.
Ready to evaluate RELI® for your mobile or home-health program? Contact our sales team to request samples, route-kit pricing, or an on-site workflow assessment.
What equipment does a mobile phlebotomy kit absolutely have to include?
At a minimum: safety-engineered needles in 21G, 23G, and 25G; a closed-system blood transfer device; a full color-coded set of evacuated tubes plus pediatric microcollection tubes; alcohol and chlorhexidine prep; single-use tourniquets; gloves; an FDA-cleared sharps container; an insulated, temperature-logged transport carrier; UN 3373 Category B compliant outer packaging for any specimen leaving the immediate site; and a barcode scanner with portable label printer plus paper-requisition backup.
Do labeling and identification rules really apply the same way in a patient's home?
Yes. CLSI GP33 and The Joint Commission NPSG.01.01.01 require two patient identifiers, bedside labeling, and no pre-labeling—on every draw, in every setting. Mobile collectors should treat home and SNF visits as identical to inpatient draws for identification purposes, not relaxed versions of them.
How long can a specimen sit in the transport carrier before it is no longer usable?
Most routine specimens are stable at ambient temperature (15–25 °C) for up to two hours and refrigerated (2–8 °C) for up to 24 hours, but every assay has its own stability window—and analytes such as potassium, lactate dehydrogenase, ammonia, and lactate fail well before the two-hour mark if not processed promptly. Reference CLSI GP44 and the receiving lab's specific requirements, and design routes around the most time-sensitive analyte you collect.
What packaging does a mobile collector need for highway or courier transport?
Diagnostic specimens are regulated under U.S. Department of Transportation and IATA Category B (UN 3373) rules: a leak-proof primary receptacle, an absorbent wrap, a leak-proof secondary container, and a rigid outer carrier marked with the UN 3373 diamond and the phrase "Biological Substance, Category B." 49 CFR 173.199 governs U.S. ground transport. A soft cooler with zip bags does not meet the standard.
How do mobile programs prevent cross-contamination between visits?
A documented between-visit reset: hand hygiene; glove change; disinfection of the kit handles, scanner, and tablet with an EPA List K registered disinfectant; single-use tourniquets discarded between every patient; and a strict separation of clean and dirty zones inside the kit. Reusable tourniquets and reused tube holders are the two highest-leverage cross-contamination risks on mobile routes.
What is the most effective single intervention for a struggling mobile program?
Standardization. The single highest-leverage change in a struggling mobile program is consolidating onto one device portfolio, one tube manufacturer, one transport carrier, and one documented bedside workflow across every route and every collector. The technique improvisation that drives mobile rejections, hemolysis, and mislabeling collapses once the supply mix and the workflow stop changing from kit to kit.
Blood Transfer Devices 101: Safer Syringe-to-Tube Workflows
Managing Difficult Blood Draws: Techniques, Tools, and Training
Stay Ready, Waste Less: Building a Sustainable, Emergency-Ready Blood Collection Program
Blood Collection Best Practices: Insights on Improving Sample Quality and Workflow Efficiency
.jpg)
.png)
.jpg)